Cara Therapeutics | CARA - 营业利润





营业利润 更改 日
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Cara Therapeutics USD -7.05M 1.11M 2026-03
Cassava Sciences USD -11.17M 2.38M 2026-03
Chugai Pharma JPY 160.86B 2.09B 2026-06
Cipla INR 8.88B 2.74B 2026-06
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 1.97B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
J&J USD 6.47B 1B 2026-09
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Pacira USD 9.96M 5.33M 2026-06
Pfizer USD 667M 4.32B 2026-06
RedHill Biopharma USD -4.22M 1.8M 2024-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12